What is CloudCath?
Founded in 2017 and headquartered in San Francisco, California, CloudCath operates within the digital health and medical device sectors. The company is dedicated to developing innovative solutions for remote complication monitoring, specifically targeting patients undergoing catheter-based treatments. This focus addresses a critical need for continuous patient oversight and proactive intervention in managing chronic conditions and post-procedure care.
How much funding has CloudCath raised?
CloudCath has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2020): $12M with participation from StartX Fund, Coconut Tree Investments, Capital Integral, The Capital Partnership, and FundRx
Key Investors in CloudCath
StartX Fund
StartX Fund is the premier startup community, accelerator, and fellowship program for over 2,500 Stanford founders, offering support without requiring equity.
FundRx
FundRx is a venture capital firm that invests in innovative healthcare and life sciences companies, leveraging a community of physicians, scientists, and executives for expertise and capital. They employ a scientific approach to investing with advanced analytics and screening capabilities.
Coconut Tree Investments
Undisclosed investor participating in the funding round.
What's next for CloudCath?
The recent major strategic investment signifies CloudCath's transition into a scaling phase, likely to fuel product development, market expansion, and further clinical validation. With a clear focus on remote patient monitoring, the company is well-positioned to capitalize on the growing trend towards telehealth and value-based healthcare. Future endeavors may include expanding its technological capabilities, forging strategic partnerships with healthcare providers, and enhancing its data analytics to provide deeper insights into patient outcomes.
See full CloudCath company page
